Economic Implications of Weight Change in Patients With Type 2 Diabetes Mellitus
Modest weight loss (>3%) among metformin-treated patients with type 2 diabetes mellitus was associated with decreased costs, lower resource utilization, and lower rates of treatment discontinuation.